# Phase 8.5 Layers Gate — TB-500

## Verdict
verdict: PASS

## Practitioner layer  (each required field: value)
- path: vault/library/peptides/tb-500/practitioner-layer.md
- present: true
- compounding_sheets_count: 0
- compounding_sheets_or_null_finding: true — explicit "NO admissible compounding-pharmacy clinical data sheet was located" null-finding present, WITH searched-vendor list (Empower Pharmacy / Empower Peptides, Tailormade / Tailor Made Compounding / Infiniwell, Hallandale, Belmar, APS, Strive, plus generic compounding-monograph/fact-sheet/data-sheet/patient-handout PDF queries). Null-finding is consistent with TB-500's non-compoundable regulatory status (removed from 503A Category 2 ~April 2026, not on Category 1, PCAC pending 23–24 July 2026; no USP/NF monograph, no FDA labeling). The gate is satisfied by the documented null-finding form.
- named_physicians_count: 1 — William A. Seeds, MD, *Peptide Protocols: Volume One*, 2020-08-24, ISBN 9780578624358 (name+venue+date verified). A4M is a society, not an individual physician. Kent Holtorf / Edwin Lee / Neil Paulvin / Tracy Gapin were searched and explicitly WITHHELD (no citable venue+date) — correctly not fabricated.
- has_bibliography: true — "Bibliography (own, with tag= + tier=)" section, 6 entries each carrying tag= and tier=.
- has_self_check: true — "Self-check" section: no-efficacy-on-these-tiers attestation, name+venue+date confirmation, data-sheet-requirement (explicit-absence form), and honest gaps/dropped-claims list.

## Non-English layer  (each required field: value)
- path: vault/library/peptides/tb-500/non-english-layer.md
- present: true
- languages_surveyed: ["Russian", "Chinese", "Other"]  (Russian + Chinese + originator-country)
  - Russian: 2 genuinely Russian-language admissible primaries (Beyrakhova et al. 2011, PMID 21721255; Makarov & Esipov 2016, DOI 10.21519/0234-2758-2016-2-57-71) + RU patents (landscape). Databases searched listed; explicit none-located for Russian in-vivo efficacy primary.
  - Chinese: 2 verified Chinese-language animal primaries (C1 PKU/CDS URL; C2 CQVIP id 29154232) + 1 located-but-unverified (C3, numerics withheld). English-published Chinese work (NL005 JCMM) correctly excluded. Search terms/databases documented.
  - Originator-country: TB-500/Tβ4 originated in the US (Goldstein) → originator literature is English; documented as a valid finding (no distinct non-English originator literature expected), satisfying the originator requirement via explicit reasoned none-located.
- has_bibliography: true — "Bibliography (own, tag= + tier= + language)" table, R1/R2/C1/C2/C3 with identifiers, tags, tiers, languages.
- has_self_check: true — "Self-check" section: ≥Russian+Chinese+originator surveyed, no fabricated citations, translated numerics tagged, genuine-vs-English-published distinction enforced, primary count stated.

## Structured verdict
```json
{"phase":"8.5","mode":"deep","practitioner_layer":{"path":"vault/library/peptides/tb-500/practitioner-layer.md","present":true,"compounding_sheets_count":0,"compounding_sheets_or_null_finding":true,"named_physicians_count":1,"has_bibliography":true,"has_self_check":true},"non_english_layer":{"path":"vault/library/peptides/tb-500/non-english-layer.md","present":true,"languages_surveyed":["Russian","Chinese","Other"],"has_bibliography":true,"has_self_check":true},"halt_reasons":[],"iterations":1}
```
